pinocembrin has been researched along with quercetin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
| Habtemariam, S | 1 |
| Bremer, R; Holder, S; Lilly, MB; Neidigh, JW; Tabrizizad, M; Zemskova, M; Zhang, C | 1 |
| Brown, ML; Holder, S; Lilly, M | 1 |
| Chen, GT; Guan, SH; Guo, DA; Huang, HL; Liu, X; Lu, ZQ; Sha, N; Xie, FB; Yue, QX | 1 |
| Carpinella, MC; Diaz Napal, GN; Palacios, SM | 1 |
| Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Batuta, S; Begum, NA; Das, S; Mitra, I; Niharul Alam, M; Roy, K | 1 |
| Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
| Defagó, MT; Diaz Napal, GN; Palacios, SM; Valladares, GR | 1 |
| Murata, RM; Pardi, V; Pasetto, S | 1 |
| Bojić, M; Debeljak, Ž; Maleš, Ž; Šarić Mustapić, D | 1 |
| Belduz, AO; Guler, HI; Kolayli, S; Tatar, G; Yildiz, O | 1 |
| Kang, Y; Kim, BG; Kim, S; Lee, Y; Yoon, Y | 1 |
1 review(s) available for pinocembrin and quercetin
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
14 other study(ies) available for pinocembrin and quercetin
| Article | Year |
|---|---|
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
Topics: Animals; Apoptosis; Drug Synergism; Flavonoids; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase.
Topics: Chromones; Crystallography, X-Ray; Flavones; Flavonoids; Humans; Male; Phenotype; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein Structure, Secondary; Proto-Oncogene Proteins c-pim-1; Sensitivity and Specificity; Substrate Specificity | 2007 |
Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Drug Design; Enzyme Inhibitors; Flavonoids; Humans; Ligands; Models, Molecular; Predictive Value of Tests; Proto-Oncogene Proteins c-pim-1; Quantitative Structure-Activity Relationship; Static Electricity; Stereoisomerism | 2007 |
Cytotoxic constituents of chinese propolis.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Female; Flavonols; Humans; Molecular Structure; Propolis; Quercetin; Stereoisomerism | 2009 |
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
Topics: Animals; Asteraceae; Biological Assay; Biotechnology; Ethanol; Flavanones; Host-Parasite Interactions; Insecticides; Models, Chemical; Pest Control, Biological; Plant Extracts; Plant Leaves; Plant Oils; Quercetin; Spodoptera | 2009 |
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
Topics: Antioxidants; Drug Design; Flavonoids; Quantitative Structure-Activity Relationship | 2014 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Response of Epilachna paenulata to two flavonoids, pinocembrin and quercetin, in a comparative study.
Topics: Animals; Body Weight; Coleoptera; Dose-Response Relationship, Drug; Feeding Behavior; Flavanones; Larva; Lethal Dose 50; Quercetin; Survival Analysis | 2010 |
Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model.
Topics: Anti-HIV Agents; Female; Flavanones; Flavonoids; Genitalia, Female; HeLa Cells; HIV Infections; HIV-1; Humans; Models, Biological; Quercetin | 2014 |
The Inhibitory Effect of Flavonoid Aglycones on the Metabolic Activity of CYP3A4 Enzyme.
Topics: Apigenin; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Flavanones; Flavones; Flavonoids; Humans; Quercetin; Testosterone | 2018 |
Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study.
Topics: Angiotensin-Converting Enzyme 2; Animals; Bees; Caffeic Acids; COVID-19 Drug Treatment; Flavanones; Flavonoids; Hesperidin; Humans; Luteolin; Molecular Docking Simulation; Phenylethyl Alcohol; Plant Extracts; Propolis; Quercetin; Rutin | 2021 |
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Binding Sites; Flavones; Flavonoids; Flavonols; Liposomes; Molecular Docking Simulation; Phosphatidylinositol Phosphates; Pleckstrin Homology Domains; Protein Binding; Quantitative Structure-Activity Relationship | 2017 |